These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3882480)

  • 1. Squaric acid dibutyl ester in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    Dermatologica; 1985; 170(1):40-2. PubMed ID: 3882480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Giannetti A; Orecchia G
    Dermatologica; 1983; 167(5):280-2. PubMed ID: 6653853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E; Şentürk N
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G; Cicero RL; Nasca MR; Sapuppo A
    Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
    Guerra L; Pacifico V; Calabresi V; De Luca N; Castiglia D; Angelo C; Zambruno G; Di Zenzo G
    Br J Dermatol; 2017 Feb; 176(2):491-494. PubMed ID: 27208509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A; Mato F; Quiñones PA
    Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH; Goh CL; Ang CB
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G; Malagoli P; Santagostino L
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
    G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE).
    Johansson E; Ranki A; Reunala T; Kianto U; Niemi KM
    Acta Derm Venereol; 1986; 66(6):485-90. PubMed ID: 2433867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of alopecia areata with squaric acid dibutylester.
    Caserio RJ
    Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
    Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
    J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Starace M; Vezzoni R; Alessandrini A; Bruni F; Carpanese MA; Misciali C; Sechi A; Piraccini BM
    Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP; Slazinski L; Fenske NA; Pullara TJ
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract]   [Full Text] [Related]  

  • 20. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E; Tay YK; Goh CL; Chin Giam Y
    Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.